AI in Genomics Market By Offering (Hardware, Software, Services), By Technology (Machine Learning, Computer Vision), By Application (Drug Discovery and Development, Precision Medicine, Diagnostics, Others), By End User (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031

AI in Genomics Market

Genomics is the study of genomes, which are the complete set of an organism's DNA, including all of its genes. The field of genomics involves analyzing and sequencing DNA, as well as studying how genes are expressed and regulated.AI in genomics refers to the use of artificial intelligence (AI) and machine learning (ML) techniques to analyze and interpret genomic data. Genomics is the study of an organism's entire genetic material, including its DNA, RNA, and other genetic material. With the advent of high-throughput sequencing technologies, it has become possible to generate vast amounts of genomic data quickly and cost-effectively. 

Key factors driving the growth of the AI in genomics market rise in investment in AI technologies. Investment in AI in genomics has been on the rise in recent years, and this trend is expected to continue. As this investment increases, it is likely to act as a major driver for AI in the genomics market. There are several factors that contribute to this. For one, the use of AI in genomics can improve the efficiency and accuracy of genomic analysis, which can lead to faster discoveries and the development of new treatments and therapies. Additionally, AI can reduce the costs associated with genomic research and analysis, making it more accessible to researchers and clinicians. As a result, more companies and organizations are likely to adopt AI in their genomics research, which will further drive growth in AI in the genomics market.  

The market also offers growth opportunities to the key players in the market. Collaboration between academia and industry in the field of genomics and AI can create significant growth opportunities for the market. With the rapid advancements in AI, genomics research has the potential to unlock new discoveries and transform healthcare. Industry can provide the necessary resources, such as funding, infrastructure, and expertise in product development, to support the research efforts of academia. In turn, academia can bring cutting-edge research and innovative ideas to the table. This collaboration can accelerate the development of new AI tools and technologies. For instance, in April 2022, BenevolentAI, a leading clinical-stage artificial intelligence (AI) enabled drug discovery company, and Drugs for Neglected Disease initiative (DNDi), a not-for-profit research and development (R&D) organization focusing on neglected diseases, announced they have begun a joint AI research project to tackle dengue, one of the world’s most prevalent infectious diseases. Furthermore, in October 2022, AstraZeneca announced two additional novel AI-generated targets for chronic kidney disease and idiopathic pulmonary fibrosis discovered using the Benevolent Platform selected to enter AstraZeneca’s drug discovery portfolio. 

Furthermore, the increase in demand for personalized medicine and growing awareness of the importance of early disease diagnosis are the key factors that drive the market growth. For instance, AI can be used to identify patients who are likely to respond well to certain drugs, allowing pharmaceutical companies to develop personalized treatments that are more effective and have fewer side effects. 

The AI in the genomics market is segmented into offering, technology, application, end-user, and region. Based on the offering, the market is segmented into software, services, and hardware. By technology, the market is segmented into machine learning and computer vision. By application, the market is segmented into drug discovery & development, precision medicine, diagnostics, and others. By end user, the market is segmented into pharmaceutical and biotech companies, healthcare providers, and research centers. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major key players that operate in the AI in genomics market are Microsoft, IBM, NVIDIA Corporation, Deep Genomics, DATA4CURE, INC, Freenome holdings, Inc, Thermo fisher scientific, Illumina, Inc., Sophia Genetics, and BenevolentAI. 

Key Market Insights  

By offering, the software segment was highest contributor to the market in 2021. However, the hardware segment is anticipated to grow at the highest CAGR during the forecast period. 

By technology, the machine learning segment dominated the market in terms of revenue in 2021.  

By applications, the drug discovery segment was highest contributor to the market in 2021. However, the diagnostics segment is anticipated to grow at the highest CAGR during the forecast period. 

By end user, the pharmaceutical and biotech companies' segment was highest contributor to the market in 2021. However, the healthcare providers segment is anticipated to grow at the highest CAGR during the forecast period.  

Region-wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. 

Overview

The global AI in genomics market was valued at $ 0.34 billion in 2021 and is projected to reach $9.9 billion by 2031, growing at a CAGR of 40.6% from 2022 to 2031.

Genomics is a branch of molecular biology that focuses on the study of the entire genetic material (DNA) of organisms. It involves the analysis of the structure, function, and evolution of genomes, including the identification of genes, their regulatory elements, and how they interact with each other. The field of genomics has grown rapidly over the last few decades due to advances in technology that have made it possible to sequence and analyze DNA more quickly and accurately. With the advent of high-throughput sequencing technologies, it is now possible to sequence entire genomes at a fraction of the cost and time that used to be required earlier. AI in the genomics market refers to the use of artificial intelligence (AI) technologies to support genomic research and applications. With the vast amount of genomic data being generated, AI tools have become increasingly important for analyzing and interpreting this data 

The driving factors for AI in the genomics market are advancements in AI technologies, growth in demand for personalized medicine, increase in adoption of genomics in research and healthcare, and rise in investment in AI in genomics. Advancements in AI technologies are the result of the development of machine learning, natural language processing, and deep learning has enabled researchers to analyze and interpret genomic data more accurately and efficiently. As AI technologies continue to improve, their application in genomics is expected to become even more widespread. Personalized medicine involves developing treatment plans tailored to individual patients based on their genomic data. As the demand for personalized medicine continues to grow, the use of AI tools in genomics is becoming increasingly important for identifying genetic variations that may be relevant to a patient's disease or condition. For instance, according to the 2022 report by National Library for Medicine, rheumatoid arthritis and psoriasis as the inflammatory disease, in addition to Alzheimer’s disease are diseases having high unmet needs for personalized medicine from the viewpoints of disease mechanisms, diagnostic biomarkers, therapeutic drugs with diagnostic markers and treatment satisfaction. 

Furthermore, genomics is becoming an increasingly important tool in both research and healthcare, as it provides important insights into the genetic basis of diseases and other conditions. This is driving the need for more advanced AI tools and technologies to analyze and interpret genomic data. However, factors such as high-cost data quality issues and limited availability of skilled professionals are expected to restrain the growth of AI in the genomics market. 

The AI in the genomics market is segmented into offering, technology, application, end-user, and region. Based on offering, the market is segmented into software, services and hardware. By technology, the market is segmented into machine learning and computer vision. By application, the market is segmented into drug discovery & development, precision medicine, diagnostics, and others. By end user, the market is segmented into pharmaceutical and biotech companies, healthcare providers, research centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major key players that operate in the AI in genomics market are Microsoft, IBM, NVIDIA Corporation, Deep Genomics, DATA4CURE, INC, Freenome holdings, Inc, Thermo fisher scientific, Illumina, Inc., Sophia Genetics, and BenevolentAI.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ai in genomics market analysis from 2021 to 2031 to identify the prevailing ai in genomics market opportunities.

Market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

An in-depth analysis of the ai in genomics market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes analysis of the regional as well as global ai in genomics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Freenome Holdings, In

Scope of AI in Genomics Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Advancements in AI technologies

3.4.1.2. Rising adoption of genomics in research and healthcare

3.4.1.3. Increase ing demand for personalized medicine

3.4.2. Restraints

3.4.2.1. Limited availability of skilled professionals

3.4.2.2. Data quality issues

3.4.3. Opportunities

3.4.3.1. Development of human aware AI

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Hardware

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Software

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Services

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Machine Learning

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Computer Vision

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Drug Discovery and Development

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Precision Medicine

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Diagnostics

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

6.5. Others

6.5.1. Key market trends, growth factors and opportunities

6.5.2. Market size and forecast, by region

6.5.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast

7.2. Pharmaceutical and Biotech Companies

7.2.1. Key market trends, growth factors and opportunities

7.2.2. Market size and forecast, by region

7.2.3. Market share analysis by country

7.3. Healthcare Providers

7.3.1. Key market trends, growth factors and opportunities

7.3.2. Market size and forecast, by region

7.3.3. Market share analysis by country

7.4. Research Centers

7.4.1. Key market trends, growth factors and opportunities

7.4.2. Market size and forecast, by region

7.4.3. Market share analysis by country

8.1. Overview

8.1.1. Market size and forecast By Region

8.2. North America

8.2.1. Key trends and opportunities

8.2.2. Market size and forecast, by Offering

8.2.3. Market size and forecast, by Technology

8.2.4. Market size and forecast, by Application

8.2.5. Market size and forecast, by End User

8.2.6. Market size and forecast, by country

8.2.6.1. U.S.

8.2.6.1.1. Key market trends, growth factors and opportunities

8.2.6.1.2. Market size and forecast, by Offering

8.2.6.1.3. Market size and forecast, by Technology

8.2.6.1.4. Market size and forecast, by Application

8.2.6.1.5. Market size and forecast, by End User

8.2.6.2. Canada

8.2.6.2.1. Key market trends, growth factors and opportunities

8.2.6.2.2. Market size and forecast, by Offering

8.2.6.2.3. Market size and forecast, by Technology

8.2.6.2.4. Market size and forecast, by Application

8.2.6.2.5. Market size and forecast, by End User

8.2.6.3. Mexico

8.2.6.3.1. Key market trends, growth factors and opportunities

8.2.6.3.2. Market size and forecast, by Offering

8.2.6.3.3. Market size and forecast, by Technology

8.2.6.3.4. Market size and forecast, by Application

8.2.6.3.5. Market size and forecast, by End User

8.3. Europe

8.3.1. Key trends and opportunities

8.3.2. Market size and forecast, by Offering

8.3.3. Market size and forecast, by Technology

8.3.4. Market size and forecast, by Application

8.3.5. Market size and forecast, by End User

8.3.6. Market size and forecast, by country

8.3.6.1. Germany

8.3.6.1.1. Key market trends, growth factors and opportunities

8.3.6.1.2. Market size and forecast, by Offering

8.3.6.1.3. Market size and forecast, by Technology

8.3.6.1.4. Market size and forecast, by Application

8.3.6.1.5. Market size and forecast, by End User

8.3.6.2. France

8.3.6.2.1. Key market trends, growth factors and opportunities

8.3.6.2.2. Market size and forecast, by Offering

8.3.6.2.3. Market size and forecast, by Technology

8.3.6.2.4. Market size and forecast, by Application

8.3.6.2.5. Market size and forecast, by End User

8.3.6.3. UK

8.3.6.3.1. Key market trends, growth factors and opportunities

8.3.6.3.2. Market size and forecast, by Offering

8.3.6.3.3. Market size and forecast, by Technology

8.3.6.3.4. Market size and forecast, by Application

8.3.6.3.5. Market size and forecast, by End User

8.3.6.4. Italy

8.3.6.4.1. Key market trends, growth factors and opportunities

8.3.6.4.2. Market size and forecast, by Offering

8.3.6.4.3. Market size and forecast, by Technology

8.3.6.4.4. Market size and forecast, by Application

8.3.6.4.5. Market size and forecast, by End User

8.3.6.5. Spain

8.3.6.5.1. Key market trends, growth factors and opportunities

8.3.6.5.2. Market size and forecast, by Offering

8.3.6.5.3. Market size and forecast, by Technology

8.3.6.5.4. Market size and forecast, by Application

8.3.6.5.5. Market size and forecast, by End User

8.3.6.6. Rest of Europe

8.3.6.6.1. Key market trends, growth factors and opportunities

8.3.6.6.2. Market size and forecast, by Offering

8.3.6.6.3. Market size and forecast, by Technology

8.3.6.6.4. Market size and forecast, by Application

8.3.6.6.5. Market size and forecast, by End User

8.4. Asia-Pacific

8.4.1. Key trends and opportunities

8.4.2. Market size and forecast, by Offering

8.4.3. Market size and forecast, by Technology

8.4.4. Market size and forecast, by Application

8.4.5. Market size and forecast, by End User

8.4.6. Market size and forecast, by country

8.4.6.1. Japan

8.4.6.1.1. Key market trends, growth factors and opportunities

8.4.6.1.2. Market size and forecast, by Offering

8.4.6.1.3. Market size and forecast, by Technology

8.4.6.1.4. Market size and forecast, by Application

8.4.6.1.5. Market size and forecast, by End User

8.4.6.2. China

8.4.6.2.1. Key market trends, growth factors and opportunities

8.4.6.2.2. Market size and forecast, by Offering

8.4.6.2.3. Market size and forecast, by Technology

8.4.6.2.4. Market size and forecast, by Application

8.4.6.2.5. Market size and forecast, by End User

8.4.6.3. Australia

8.4.6.3.1. Key market trends, growth factors and opportunities

8.4.6.3.2. Market size and forecast, by Offering

8.4.6.3.3. Market size and forecast, by Technology

8.4.6.3.4. Market size and forecast, by Application

8.4.6.3.5. Market size and forecast, by End User

8.4.6.4. India

8.4.6.4.1. Key market trends, growth factors and opportunities

8.4.6.4.2. Market size and forecast, by Offering

8.4.6.4.3. Market size and forecast, by Technology

8.4.6.4.4. Market size and forecast, by Application

8.4.6.4.5. Market size and forecast, by End User

8.4.6.5. South Korea

8.4.6.5.1. Key market trends, growth factors and opportunities

8.4.6.5.2. Market size and forecast, by Offering

8.4.6.5.3. Market size and forecast, by Technology

8.4.6.5.4. Market size and forecast, by Application

8.4.6.5.5. Market size and forecast, by End User

8.4.6.6. Rest of Asia-Pacific

8.4.6.6.1. Key market trends, growth factors and opportunities

8.4.6.6.2. Market size and forecast, by Offering

8.4.6.6.3. Market size and forecast, by Technology

8.4.6.6.4. Market size and forecast, by Application

8.4.6.6.5. Market size and forecast, by End User

8.5. LAMEA

8.5.1. Key trends and opportunities

8.5.2. Market size and forecast, by Offering

8.5.3. Market size and forecast, by Technology

8.5.4. Market size and forecast, by Application

8.5.5. Market size and forecast, by End User

8.5.6. Market size and forecast, by country

8.5.6.1. Brazil

8.5.6.1.1. Key market trends, growth factors and opportunities

8.5.6.1.2. Market size and forecast, by Offering

8.5.6.1.3. Market size and forecast, by Technology

8.5.6.1.4. Market size and forecast, by Application

8.5.6.1.5. Market size and forecast, by End User

8.5.6.2. Saudi Arabia

8.5.6.2.1. Key market trends, growth factors and opportunities

8.5.6.2.2. Market size and forecast, by Offering

8.5.6.2.3. Market size and forecast, by Technology

8.5.6.2.4. Market size and forecast, by Application

8.5.6.2.5. Market size and forecast, by End User

8.5.6.3. South Africa

8.5.6.3.1. Key market trends, growth factors and opportunities

8.5.6.3.2. Market size and forecast, by Offering

8.5.6.3.3. Market size and forecast, by Technology

8.5.6.3.4. Market size and forecast, by Application

8.5.6.3.5. Market size and forecast, by End User

8.5.6.4. Rest of LAMEA

8.5.6.4.1. Key market trends, growth factors and opportunities

8.5.6.4.2. Market size and forecast, by Offering

8.5.6.4.3. Market size and forecast, by Technology

8.5.6.4.4. Market size and forecast, by Application

8.5.6.4.5. Market size and forecast, by End User

9.1. Introduction

9.2. Top winning strategies

9.3. Product Mapping of Top 10 Player

9.4. Competitive Dashboard

9.5. Competitive Heatmap

9.6. Top player positioning, 2021

10.1. Microsoft Corporation

10.1.1. Company overview

10.1.2. Key Executives

10.1.3. Company snapshot

10.1.4. Operating business segments

10.1.5. Product portfolio

10.1.6. Business performance

10.1.7. Key strategic moves and developments

10.2. IBM Corporation

10.2.1. Company overview

10.2.2. Key Executives

10.2.3. Company snapshot

10.2.4. Operating business segments

10.2.5. Product portfolio

10.2.6. Business performance

10.2.7. Key strategic moves and developments

10.3. NVIDIA Corporation (Mellanox Technologies)

10.3.1. Company overview

10.3.2. Key Executives

10.3.3. Company snapshot

10.3.4. Operating business segments

10.3.5. Product portfolio

10.3.6. Business performance

10.3.7. Key strategic moves and developments

10.4. Deep Genomics

10.4.1. Company overview

10.4.2. Key Executives

10.4.3. Company snapshot

10.4.4. Operating business segments

10.4.5. Product portfolio

10.4.6. Key strategic moves and developments

10.5. Data4Cure, Inc

10.5.1. Company overview

10.5.2. Key Executives

10.5.3. Company snapshot

10.5.4. Operating business segments

10.5.5. Product portfolio

10.6. Freenome Holdings, Inc

10.6.1. Company overview

10.6.2. Key Executives

10.6.3. Company snapshot

10.6.4. Operating business segments

10.6.5. Product portfolio

10.7. Thermo Fisher Scientific Inc.

10.7.1. Company overview

10.7.2. Key Executives

10.7.3. Company snapshot

10.7.4. Operating business segments

10.7.5. Product portfolio

10.7.6. Business performance

10.8. Illumina, Inc.

10.8.1. Company overview

10.8.2. Key Executives

10.8.3. Company snapshot

10.8.4. Operating business segments

10.8.5. Product portfolio

10.8.6. Business performance

10.8.7. Key strategic moves and developments

10.9. Sophia Genetics

10.9.1. Company overview

10.9.2. Key Executives

10.9.3. Company snapshot

10.9.4. Operating business segments

10.9.5. Product portfolio

10.9.6. Business performance

10.10. BenevolentAI

10.10.1. Company overview

10.10.2. Key Executives

10.10.3. Company snapshot

10.10.4. Operating business segments

10.10.5. Product portfolio

10.10.6. Key strategic moves and development

LIST OF TABLES

TABLE 01. GLOBAL AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 02. AI IN GENOMICS MARKET FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)

TABLE 03. AI IN GENOMICS MARKET FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)

TABLE 04. AI IN GENOMICS MARKET FOR SERVICES, BY REGION, 2021-2031 ($MILLION)

TABLE 05. GLOBAL AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 06. AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY REGION, 2021-2031 ($MILLION)

TABLE 07. AI IN GENOMICS MARKET FOR COMPUTER VISION, BY REGION, 2021-2031 ($MILLION)

TABLE 08. GLOBAL AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 09. AI IN GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2021-2031 ($MILLION)

TABLE 10. AI IN GENOMICS MARKET FOR PRECISION MEDICINE, BY REGION, 2021-2031 ($MILLION)

TABLE 11. AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)

TABLE 12. AI IN GENOMICS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 13. GLOBAL AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 14. AI IN GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2021-2031 ($MILLION)

TABLE 15. AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2021-2031 ($MILLION)

TABLE 16. AI IN GENOMICS MARKET FOR RESEARCH CENTERS, BY REGION, 2021-2031 ($MILLION)

TABLE 17. AI IN GENOMICS MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 18. NORTH AMERICA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 19. NORTH AMERICA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 20. NORTH AMERICA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 21. NORTH AMERICA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 22. NORTH AMERICA AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 23. U.S. AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 24. U.S. AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 25. U.S. AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 26. U.S. AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 27. CANADA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 28. CANADA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 29. CANADA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 30. CANADA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 31. MEXICO AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 32. MEXICO AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 33. MEXICO AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 34. MEXICO AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 35. EUROPE AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 36. EUROPE AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 37. EUROPE AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 38. EUROPE AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 39. EUROPE AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 40. GERMANY AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 41. GERMANY AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 42. GERMANY AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 43. GERMANY AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 44. FRANCE AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 45. FRANCE AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 46. FRANCE AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 47. FRANCE AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 48. UK AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 49. UK AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 50. UK AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 51. UK AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 52. ITALY AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 53. ITALY AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 54. ITALY AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 55. ITALY AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 56. SPAIN AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 57. SPAIN AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 58. SPAIN AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 59. SPAIN AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 60. REST OF EUROPE AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 61. REST OF EUROPE AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 62. REST OF EUROPE AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 63. REST OF EUROPE AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 64. ASIA-PACIFIC AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 65. ASIA-PACIFIC AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 66. ASIA-PACIFIC AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 67. ASIA-PACIFIC AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 68. ASIA-PACIFIC AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 69. JAPAN AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 70. JAPAN AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 71. JAPAN AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 72. JAPAN AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 73. CHINA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 74. CHINA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 75. CHINA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 76. CHINA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 77. AUSTRALIA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 78. AUSTRALIA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 79. AUSTRALIA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 80. AUSTRALIA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 81. INDIA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 82. INDIA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 83. INDIA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 84. INDIA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 85. SOUTH KOREA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 86. SOUTH KOREA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 87. SOUTH KOREA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 88. SOUTH KOREA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 89. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 90. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 91. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 92. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 93. LAMEA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 94. LAMEA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 95. LAMEA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 96. LAMEA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 97. LAMEA AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 98. BRAZIL AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 99. BRAZIL AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 100. BRAZIL AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 101. BRAZIL AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 102. SAUDI ARABIA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 103. SAUDI ARABIA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 104. SAUDI ARABIA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 105. SAUDI ARABIA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 106. SOUTH AFRICA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 107. SOUTH AFRICA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 108. SOUTH AFRICA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 109. SOUTH AFRICA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 110. REST OF LAMEA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)

TABLE 111. REST OF LAMEA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)

TABLE 112. REST OF LAMEA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 113. REST OF LAMEA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 114. MICROSOFT CORPORATION: KEY EXECUTIVES

TABLE 115. MICROSOFT CORPORATION: COMPANY SNAPSHOT

TABLE 116. MICROSOFT CORPORATION: SERVICE SEGMENTS

TABLE 117. MICROSOFT CORPORATION: PRODUCT PORTFOLIO

TABLE 118. MICROSOFT CORPORATION: KEY STRATERGIES

TABLE 119. IBM CORPORATION: KEY EXECUTIVES

TABLE 120. IBM CORPORATION: COMPANY SNAPSHOT

TABLE 121. IBM CORPORATION: SERVICE SEGMENTS

TABLE 122. IBM CORPORATION: PRODUCT PORTFOLIO

TABLE 123. IBM CORPORATION: KEY STRATERGIES

TABLE 124. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): KEY EXECUTIVES

TABLE 125. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): COMPANY SNAPSHOT

TABLE 126. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): PRODUCT SEGMENTS

TABLE 127. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): PRODUCT PORTFOLIO

TABLE 128. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): KEY STRATERGIES

TABLE 129. DEEP GENOMICS: KEY EXECUTIVES

TABLE 130. DEEP GENOMICS: COMPANY SNAPSHOT

TABLE 131. DEEP GENOMICS: SERVICE SEGMENTS

TABLE 132. DEEP GENOMICS: PRODUCT PORTFOLIO

TABLE 133. DEEP GENOMICS: KEY STRATERGIES

TABLE 134. DATA4CURE, INC: KEY EXECUTIVES

TABLE 135. DATA4CURE, INC: COMPANY SNAPSHOT

TABLE 136. DATA4CURE, INC: SERVICE SEGMENTS

TABLE 137. DATA4CURE, INC: PRODUCT PORTFOLIO

TABLE 138. FREENOME HOLDINGS, INC: KEY EXECUTIVES

TABLE 139. FREENOME HOLDINGS, INC: COMPANY SNAPSHOT

TABLE 140. FREENOME HOLDINGS, INC: SERVICE SEGMENTS

TABLE 141. FREENOME HOLDINGS, INC: PRODUCT PORTFOLIO

TABLE 142. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES

TABLE 143. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT

TABLE 144. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS

TABLE 145. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO

TABLE 146. ILLUMINA, INC.: KEY EXECUTIVES

TABLE 147. ILLUMINA, INC.: COMPANY SNAPSHOT

TABLE 148. ILLUMINA, INC.: PRODUCT SEGMENTS

TABLE 149. ILLUMINA, INC.: PRODUCT PORTFOLIO

TABLE 150. ILLUMINA, INC.: KEY STRATERGIES

TABLE 151. SOPHIA GENETICS: KEY EXECUTIVES

TABLE 152. SOPHIA GENETICS: COMPANY SNAPSHOT

TABLE 153. SOPHIA GENETICS: PRODUCT SEGMENTS

TABLE 154. SOPHIA GENETICS: SERVICE SEGMENTS

TABLE 155. SOPHIA GENETICS: PRODUCT PORTFOLIO

TABLE 156. BENEVOLENTAI: KEY EXECUTIVES

TABLE 157. BENEVOLENTAI: COMPANY SNAPSHOT

TABLE 158. BENEVOLENTAI: SERVICE SEGMENTS

TABLE 159. BENEVOLENTAI: PRODUCT PORTFOLIO

TABLE 160. BENEVOLENTAI: KEY STRATERGIES LIST OF FIGURES

FIGURE 01. AI IN GENOMICS MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF AI IN GENOMICS MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN AI IN GENOMICS MARKET (2022-2031)

FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 05. LOW BARGAINING POWER OF BUYERS

FIGURE 06. LOW THREAT OF SUBSTITUTES

FIGURE 07. LOW THREAT OF NEW ENTRANTS

FIGURE 08. LOW INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALAI IN GENOMICS MARKET

FIGURE 10. AI IN GENOMICS MARKET, BY OFFERING, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR HARDWARE, BY COUNTRY 2021 AND 2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR SOFTWARE, BY COUNTRY 2021 AND 2031(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR SERVICES, BY COUNTRY 2021 AND 2031(%)

FIGURE 14. AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY COUNTRY 2021 AND 2031(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR COMPUTER VISION, BY COUNTRY 2021 AND 2031(%)

FIGURE 17. AI IN GENOMICS MARKET, BY APPLICATION, 2021(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY 2021 AND 2031(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR PRECISION MEDICINE, BY COUNTRY 2021 AND 2031(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY 2021 AND 2031(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 22. AI IN GENOMICS MARKET, BY END USER, 2021(%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY 2021 AND 2031(%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 25. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR RESEARCH CENTERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 26. AI IN GENOMICS MARKET BY REGION, 2021

FIGURE 27. U.S. AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 28. CANADA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 29. MEXICO AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 30. GERMANY AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 31. FRANCE AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 32. UK AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 33. ITALY AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 34. SPAIN AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 35. REST OF EUROPE AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 36. JAPAN AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 37. CHINA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 38. AUSTRALIA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 39. INDIA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 40. SOUTH KOREA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 41. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 42. BRAZIL AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 43. SAUDI ARABIA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 44. SOUTH AFRICA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 45. REST OF LAMEA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)

FIGURE 46. TOP WINNING STRATEGIES, BY YEAR

FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 50. COMPETITIVE DASHBOARD

FIGURE 51. COMPETITIVE HEATMAP: AI IN GENOMICS MARKET

FIGURE 52. TOP PLAYER POSITIONING, 2021

FIGURE 53. MICROSOFT CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 54. MICROSOFT CORPORATION.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)

FIGURE 55. MICROSOFT CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 56. MICROSOFT CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 57. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 58. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021

FIGURE 59. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 60. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 61. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): NET REVENUE, 2020-2022 ($MILLION)

FIGURE 62. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022

FIGURE 63. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 64. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): REVENUE SHARE BY REGION, 2022 (%)

FIGURE 65. THERMO FISHER SCIENTIFIC INC.: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 66. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 67. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 68. ILLUMINA, INC.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 69. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 70. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 71. SOPHIA GENETICS: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 72. SOPHIA GENETICS: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 73. SOPHIA GENETICS: REVENUE SHARE BY REGION, 2021 (%